Abstract
Calcium-activated chloride channels (CaCCs) are essential for epithelial secretion, neuronal transmission, and smooth muscle function. Among the Anoctamin family, Anoctamin 1 (ANO1) and Anoctamin 2 (ANO2) are classical CaCCs proteins. ANO1 has been identified as a potential therapeutic target due to its involvement in diseases such as cancer and cystic fibrosis. However, current high-throughput screening (HTS) systems face limitations in achieving subtype-specific detection and optimizing screening strategies. Stable HTS cell models expressing ANO1 or ANO2 were constructed via lentiviral transduction in Fischer mouse thyroid (FRT) cells. The models were validated using flow cytometry, Reverse Transcription Polymerase Chain Reaction(RT-PCR), and YFP-H148Q/I152L-based iodide fluorescence quenching assays. Patch-clamp electrophysiology was employed to characterize ANO1 and ANO2 current properties. Although these electrophysiological features have been previously reported, their application in HTS workflows had not been systematically evaluated. ANO1 displayed notable current rundown under sustained stimulation with high Ca2+ or agonist concentrations, whereas ANO2 maintained stable currents under identical conditions. Based on these findings, an optimized screening strategy was developed, incorporating agonist concentration gradients and the timing of inhibitor application. This approach improved the specificity and reliability of modulator detection. A robust and functionally validated cell-based HTS platform for CaCCs modulator discovery was established. By integrating the electrophysiological characteristics of ANO1 into the screening design, the optimized strategy enhances the accuracy of identifying selective ANO1 modulators. This work provides a methodological basis for future mechanism-driven screening of CaCCs-targeted compounds.
Data availability
Raw data and images can be obtained from the corresponding authors.
References
Yang, Y. D. et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 455 (7217), 1210–1215 (2008).
Caputo, A. et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science. 322(5901), 590–594 (2008).
Schroeder, B. C. et al. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 134(6), 1019–1029 (2008).
Mansoura, M. K. et al. Fluorescent chloride indicators to assess the efficacy of CFTR cDNA delivery. Hum. Gene Ther. 10(6), 861–875 (1999).
Scudieri, P. et al. TMEM16A-TMEM16B chimaeras to investigate the structure-function relationship of calcium-activated chloride channels. Biochem. J. 452(3), 443–455 (2013).
Rhoden, K. J. et al. Cell-based imaging of sodium iodide symporter activity with the yellow fluorescent protein variant YFP-H148Q/I152L. Am. J. Physiol. Cell. Physiol. 292(2), C814–C823 (2007).
Seo, Y. et al. Ani9, A novel potent Small-Molecule ANO1 inhibitor with negligible effect on ANO2. PloS One. 11(5), e0155771 (2016).
Oh, S. J. et al. MONNA, a potent and selective blocker for transmembrane protein with unknown function 16/anoctamin-1. Mol. Pharmacol. 84 (5), 726–735 (2013).
Liu, Y. et al. Volume-regulated Cl(-) current: contributions of distinct Cl(-) channels and localized Ca(2+) signals. Am. J. Physiol. Cell. Physiol. 317(3), C466–c80 (2019).
Zheng, K. et al. [Effect of enhanced green fluorescent protein fusion on Ano1 physiological feature]. Sheng Li Xue Bao. 67(6), 623–628 (2015).
Cabrita, I. et al. Differential effects of Anoctamins on intracellular calcium signals. FASEB J. 31(5): 2123–2134. (2017).
Namkung, W., Phuan, P. W. & Verkman, A. S. TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J. Biol. Chem. 286(3), 2365–2374 (2011).
Obergrussberger, A. et al. Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade. Expert Opin. Drug Discov. 16(1), 1–5 (2021).
Verhoeckx, K. et al. The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models (Cham, Springer, 2015).
BRITSCHGI, A. et al. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc. Natl. Acad. Sci. U.S.A. 110(11), E1026–E1034 (2013).
Li, Y., Zhang, J. & Hong, S. ANO1 as a marker of oral squamous cell carcinoma and Silencing ANO1 suppresses migration of human SCC-25 cells. Med. Oral. Patol. Oral. Cir. Bucal. 19(4): e313–e319 (2014).
Seo, Y. et al. Inhibition of ANO1/TMEM16A chloride channel by idebenone and its cytotoxicity to cancer cell lines. PloS One. 10(7), e0133656 (2015).
Taylor, R. D., Jewsbury, P. J. & Essex, J. W. A review of protein-small molecule Docking methods. J. Comput. Aided Mol. Des. 16(3), 151–166 (2002).
HAGA, J. H. & ICHIKAWA, K. Virtual screening techniques and current computational infrastructures. Curr. Pharm. Design. 22(23) 3576–3584 (2016).
Lee, Y. H. & Yi, G. S. Prediction of novel Anoctamin1 (ANO1) inhibitors using 3D-QSAR pharmacophore modeling and molecular Docking. Int. J. Mol. Sci. 19(10) (2018).
Choi, S. H. et al. Anti-glioma effects of 2-aminothiophene-3-carboxamide derivatives, ANO1 channel blockers. Eur. J. Med. Chem. 208 112688 (2020).
Paulino, C. et al. Structural basis for anion conduction in the calcium-activated chloride channel TMEM16A. eLife. 6 (2017).
Dang, S. et al. Cryo-EM structures of the TMEM16A calcium-activated chloride channel. Nature 552(7685), 426–429 (2017).
Ousingsawat, J. et al. Inhibition of mucus secretion by niclosamide and benzbromarone in airways and intestine. Sci. Rep. 14(1), 1464 (2024).
Strege, P. R. et al. EAVK segment c sequence confers Ca(2+)-dependent changes to the kinetics of full-length human Ano1. Am. J. Physiol. Gastrointest. Liver Physiol. 312(6), G572–g9 (2017).
Shin, Y. et al. Epigenetic modification as a regulatory mechanism for Spatiotemporal dynamics of ANO1 expression in salivary glands. Int. J. Mol. Sci. 20(24). (2019).
Duvvuri, U. et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 72(13), 3270–3281 (2012).
Pedemonte, N. & Galietta, L. J. Structure and function of TMEM16 proteins (anoctamins). Physiol. Rev. 94(2), 419–459 (2014).
QU, Z. & YAO, W. The Ca(2+) -activated Cl(-) channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis. Cancer Med. 3(3), 453–461 (2014).
RUIZ, C. et al. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis. PloS One. 7(8), e43265 (2012).
Pinto, M. C. et al. Systems approaches to unravel molecular function: High-content SiRNA screen identifies TMEM16A traffic regulators as potential drug targets for cystic fibrosis. J. Mol. Biol. 434(5), 167436 (2022).
Wu, A. et al. TMEM16A antagonism: therapeutic potential with desensitization of β-Agonist responsiveness in asthma. Am. J. Respir. Cell Mol. Biol. 72(5), 510–519 (2025).
CAO, X. et al. Opposing roles of E3 ligases TRIM23 and TRIM21 in regulation of ion channel ANO1 protein levels. J. Biol. Chem. 296, 100738 (2021).
Jiang, Y. et al. MicroRNA–144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer. Oncol. Rep. 41(4), 2361–2370 (2019).
Mitri, C. et al. TMEM16A/ANO1: current strategies and novel drug approaches for cystic fibrosis. Cells. 10(11) (2021).
Seo, Y., Anh N. H., Heo, Y. et al. Novel ANO1 inhibitor from Mallotus Apelta extract exerts anticancer activity through downregulation of ANO1. Int. J. Mol. Sci. 21(18) (2020).
Duran, C. et al. ANOs 3–7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins. Am. J. Physiol. Cell. Physiol. 302(3), C482–C493 (2012).
Schreiber, R. et al. Expression and function of epithelial Anoctamins. J. Biol. Chem. 285(10), 7838–7845 (2010).
Tian, Y., Schreiber, R. & Kunzelmann, K. Anoctamins are a family of Ca2+-activated Cl- channels. J. Cell Sci. 125(Pt 21), 4991–4998 (2012).
MACARRON, R. et al. Impact of high-throughput screening in biomedical research. Nat. Rev. Drug Discovery. 10(3), 188–195 (2011).
Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 83(3), 770–803 (2020).
Li, J. W. & Vederas, J. C. Drug discovery and natural products: End of an era or an endless frontier?. 325(5937), 161–165 (2009).
Namkung, W. et al. Inhibition of Ca2+-activated Cl− channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea. FASEB J. 24(11), 4178–4186 (2010).
Seo, Y. et al. Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors. Eur. J. Med. Chem. 160, 245–255 (2018).
Lee, J. et al. Two helices in the third intracellular loop determine Anoctamin 1 (TMEM16A) activation by calcium. Pflug, Arch.: Eur. J. Physiol. 467(8), 1677–1687 (2015).
Yang, T., Hendrickson, W. A. & Colecraft, H. M. Preassociated Apocalmodulin mediates Ca2+-dependent sensitization of activation and inactivation of TMEM16A/16B Ca2+-gated Cl- channels. Proc. Natl. Acad. Sci. U.S.A. 111(51), 18213–18218 (2014).
Ponissery Saidu, S. et al. Channel properties of the splicing isoforms of the olfactory calcium-activated chloride channel Anoctamin 2. J. Gen. Physiol. 141(6), 691–703 (2013).
Pifferi, S., Dibattista, M. & Menini, A. TMEM16B induces chloride currents activated by calcium in mammalian cells. Pflug, Arch.: Eur. J. Physiol. 458(6), 1023–1038 (2009).
Alvarez, O., Gonzalez, C. & Latorre, R. Counting channels: a tutorial guide on ion channel fluctuation analysis. Adv. Physiol. Educ. 26(1–4), 327–41 (2002).
Nirenberg, V. A. & Yifrach, O. Bridging the molecular-cellular gap in understanding ion channel clustering. Front. Pharmacol. 10, 1644 (2019).
Acknowledgements
Y.W., K.Z., K.Q., W.Z. and F.H. contributed equally to this work, and they are responsible for the idea, funding, and paper editing.
Funding
This work was partly supported by the Project of Jilin Provincial Department of Education (JJKH20220462KJ, JJKH20220473SK and JJKH20240596KJ), the Project of Science and Technology Department of Jilin Province (YDZJ202401007ZYTS), Jilin Medical College graduate innovation program (2023zyc04), “Meikang Shengde” student scientific research and innovation project of Inspection College of Jilin Medical University(2023jymkz002), Jilin University of Medicine 2024 College Student Innovation and Entrepreneurship Training Program (S202413706007), Jilin Province Health and Health Technology Capacity Enhancement Project (2024A094), National Natural Science Foundation of China(81173109).
Author information
Authors and Affiliations
Contributions
Y.W. and K.Z. conceived of and designed the research. L.Y., L.L., H.H., S.C., and Z.Q. performed the experiments. W.Z. and F.H. interpreted the results of the experiments. Y.W. and K.Z. drafted the manuscript and edited and revised the manuscript. All authors read and approved the final.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wang, Y., Zheng, K., Yang, L. et al. Research and optimization of screening strategy for calcium-activated chloride channel modulators guided by electrophysiological characteristics. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39762-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-39762-3
